As 84% of EC is Type I endometrioid adenocarcinoma, which has a stronger association with obesity than does non-endometrioid Type 2 EC, obesity with its concomitant increased estradiol and insulin levels, remains a risk factor for EC [7,8,9,10]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.